Biomarkers to predict the clinical efficacy of bevacizumab in advanced colorectal cancer: KRAS mutational status of circulating tumor cells.
2014 ◽
Vol 32
(15_suppl)
◽
pp. e22030-e22030
2019 ◽
Vol 34
(4)
◽
pp. 589-597
◽
2014 ◽
Vol 32
(15_suppl)
◽
pp. e22026-e22026
Keyword(s):
2010 ◽
Vol 28
(15_suppl)
◽
pp. e14113-e14113
Keyword(s):
2018 ◽
Vol Volume 10
◽
pp. 4135-4144
◽
1997 ◽
Vol 8
(Supplement 2)
◽
pp. S11-S15
◽